MedTrace Logo

Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience

NCT03240510 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2017-08-07

No results posted yet for this study

Summary

The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years.

Goal of the retrospective part: to gather clinicopathologic data and follow-up outcomes of male breast cancer patients diagnosed and/or treated at Salah Azaïz Cancer Institute from 2004 to 2013.

Goal of the prospective part: to create a registry of male patients with breast cancer for a period of 48 months (from 2014 to 2017).

Conditions

  • Male Breast Cancer

Sponsors & Collaborators

  • Salah Azaïz Cancer Institute

    lead OTHER

Principal Investigators

  • Syrine Abdeljaoued, PhD · Salah Azaïz Cancer Institute

  • Ilhem Bettaieb, Dr · Salah Azaïz Cancer Institute

  • Amor Gamoudi, Pr · Salah Azaïz Cancer Institute

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2016-12-31
Completion
2018-01-01

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03240510 on ClinicalTrials.gov